MME and acute lymphoblastic leukemia: The above-mentioned classification (ICC) also considers KMT2A-r B-ALL diagnostic considerations and ancillary testing—CD10 nonspecific but characteristically dim/negative, the presence of CD15, the absence of CD24, KMT2A break apart in fluorescence in situ hybridization (FISH), and the use of targeted transcriptome sequencing.